BULLOUS PEMPHIGOID
Clinical trials for BULLOUS PEMPHIGOID explained in plain language.
Never miss a new study
Get alerted when new BULLOUS PEMPHIGOID trials appear
Sign up with your email to follow new studies for BULLOUS PEMPHIGOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody treatment offers hope for rare blistering skin disease
Disease control Recruiting nowThis study tests a new drug called CM336 in 30 adults with moderate to severe autoimmune bullous disease, a condition where the immune system attacks the skin causing painful blisters. The drug targets specific immune cells to reduce this attack. The main goal is to see if the dr…
Matched conditions: BULLOUS PEMPHIGOID
Phase: PHASE2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Scientists probe hidden clot risks in autoimmune skin disorders
Knowledge-focused Recruiting nowThis study looks at blood clotting in people with autoimmune skin diseases like bullous pemphigoid and lupus. Researchers will collect blood samples from 39 participants—some with active disease and some with mild or controlled disease—plus 15 healthy controls. They will measure …
Matched conditions: BULLOUS PEMPHIGOID
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Researchers track blistering skin disease to pave way for better treatments
Knowledge-focused Recruiting nowThis study looks at how severe autoimmune blistering diseases like pemphigus and bullous pemphigoid are and how they affect quality of life. Researchers will enroll 150 adults to test disease severity scales and quality-of-life questionnaires. The goal is to create better tools f…
Matched conditions: BULLOUS PEMPHIGOID
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC